# Rayner acquires stake in Reper to boost R&D and Russian presence

Rayner, a UK-based ophthalmic implant manufacturer, has acquired a substantial stake in Reper, a Russian material science and medical device company, following a four-year R&D collaboration on a hydrophobic IOL material. Financial terms are not disclosed.

- Type: Acquisition
- Announced: 2019-09-01
- Status: announced
- Products: intraocular lenses, hydrophobic IOL material
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Rayner](https://endata.com/companies/33328.md) (acquirer)
- [Reper](https://endata.com/companies/41761.md) (target)

## Sources

- [rayner.com](https://rayner.com/us/rayner-partners-and-acquires-stake-in-reper-to-drive-rd-and-build-presence-in-russia/), 2019-09-01: "Reper became an important partner for Rayner with several new and exciting R&D projects in the pipeline in cataract and beyond."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.